Dermatology Times, April 2019 (Vol. 40, No. 4)

Learn about the most important surgical and medical advancements in skin cancer treatments as they developed over time.

Learn about the evolution of aesthetic lasers from their theoretical origins to the advanced medical devices we have today.

Hosted by Dermatology Times and supported by Ortho Dermatologics, the hall of fame honored its inaugural class of inductees at the Long View Gallery in Washington, D.C., just before the 2019 American Academy of Dermatology Annual Meeting.

Ryan Suydam, chief experience officer at Client Savvy, wants your patients to have an excellent experience. That’s why he’s sharing his top five tips to improve the patient experience, which will not only help you attract new patients – it will keep your current patients coming back to your practice.

Discover how the study of skin evolved over time until it was recognized as a distinct medical specialty in the 18th and 19th centuries.

PricewaterhouseCoopers believes 2019 is the year a New Health Economy comes of age, according to its 13th annual report, "Top health industry issues of 2019." View the top six takeaways from the report in this slideshow.

The Dermatology Innovation Forum, a one-day pre-AAD meeting, gives physicians a frontline seat to founder stories, new innovations and major advances happening currently in dermatology. Here are some of the highlights from the 2019 DIF conference.

In this month's Cosmetic Conundrums, Zoe Diana Draelos, M.D., addresses treatments for nail ridges, the safety of gel nails and minimizing the pain of onycholysis. 

According to this expert, honesty is the best policy – especially when appealing to insurance carriers on behalf of your patients.

In this month's Legal Eagle column, David J. Goldberg, M.D., J.D. discusses a scenario in which a physician tries to provide a better treatment option at a lower cost for his underinsured patients by importing medication from another country, but is reprimanded by the FDA. Find out why.

Expert calls for FDA approval of devices for women’s genitourinary health: “Women need these treatments.”

Skin concerns and treatment approaches differ for and among patients with skin of color.

If you want to get paid promptly in 2019, don't get too comfortable with biopsy codes you've been using for years, says Alexander Miller, M.D., F.A.A.D. Read more from his presentation on coding and office management from the American Academy of Dermatology Annual Meeting in Washington, D.C.

As an expert on coding and office management, Mark D. Kaufmann, M.D., explained important role the AMA's Specialty Society Relative Value Update Committee (RUC) plays in code valuation during his presentation at the American Academy of Dermatology Annual Meeting in Washington, D.C.

With a crowded indication that includes 14 systemic agents, is there really room for tyrosine kinase 2 (Tyk2) inhibitors to treat psoriasis? This physician thinks so.

Drug-device combination, VP-102, met all primary and secondary endpoints in the parallel Cantharidin Application in Molluscum Patients (CAMP)-1 and CAMP-2 trials.

While this new class of medications still has a role in treating psoriasis, this physician says the standard for both their efficacy and safety is very high because of the existing, already very effective systemic therapies available today.

Fillers and skin tightening technologies provide safe, synergistic results.